The following are key actions taken by the ACAAI Board of Regents during its May 15 meeting and the Executive Committee during its July 19 meeting.
- Ratified the decision to develop a webinar on COVID-19 vaccinations.
- Ratified the decision to participate in the AMA’s Telehealth Immersion Program.
- Accepted the unaudited Financial Statements for the period ending 3/31/21.
- Accepted the final audited Financial Statements for the period ending 12/31/20.
- Approved the applications submitted by the Credentials Committee for Fellowship, Promotion to Fellowship, Scientific Fellowship, Membership, Allied Health, Fellow-in-Training and Resident/Medical Student Membership.
- Approved the Credentials Committee’s recommendations for Retired and Emeritus Status for the named Fellows and Members.
- Approved the 2022 Joint Board Review Course be held using a virtual methodology, with pre-recorded presentations as recommended.
- Approved the 2021 Annual Scientific Meeting Program.
- Approved working with the Canadian Society of Allergy and Clinical Immunology to produce a joint Pediatric Allergy Meeting in 2022 and 2024 as outlined and authorized the President to sign the MOU as presented to formalize the arrangement.
- Appointed David Stukus, MD, FACAAI as co-chair and Maureen Petersen, MD, FACAAI and Anna Nowak-Wegrzyn, MD, PhD, FACAAI as members of the 2021-2022 joint CSACI/ACAAI program planning committee to develop the program for the 2022 Joint Pediatric Allergy Meeting that will be held during the CSACI Annual Meeting in Quebec City and managed by CSACI.
- Approved contracting with PRA/Mardi Gras World to hold the 2021 Annual Meeting Welcome Reception at Mardi Gras World.
- Approved the Annals Editor-in-Chief contract as presented to enable Mitchell Grayson, MD, FACAAI to assume the role of Editor-in-Chief beginning Jan. 1, 2022.
- Approved the establishment of an Annals Editor-in-Chief Emeritus position, and agreed to honor Gailen Marshall, Jr., MD, PhD, FACAAI with this title beginning Jan. 1, 2022 and continuing through Dec. 31, 2025.
- Approved the establishment of a temporary Annals Senior Executive Editor position and appointed Donald Leung, MD, PhD, FACAAI to serve in this role for one year beginning Jan. 1, 2022 and continuing through Dec. 31, 2022.
- Appointed John Oppenheimer, MD, FACAAI as Annals Executive Editor beginning Jan. 1, 2022.
- Appointed Jonathan Spergel, MD, PhD, FACAAI as Annals Deputy Editor position beginning Jan. 1, 2022.
- Appointed Larry Borish, MD, FACAAI, Mariana Castells, MD, PhD, FACAAI, Jay Lieberman, MD, FACAAI and Anna Nowak-Wegrzyn, MD, PhD, FACAAI as Annals Associate Editors beginning Jan. 1, 2022.
- Appointed David Stukus, MD, FACAAI and Marcus Shaker, MD, FACAAI as Annals Associate Editors beginning Oct. 1, 2021.
- Approved the establishment of an Annals Senior Associate Editor position and appointed Matthew Greenhawt, MD, MBA, MSc, FACAAI to serve in the role beginning Jan. 1, 2022.
- Authorized Aimmune and its contracted vendor to validate the College’s Peanut OIT Shared Decision-Making Tool and appointed Tricia Lee, MD to serve on the project’s Steering Committee.
- Requested staff to work with legal counsel to copyright the College’s Peanut OIT Shared Decision-Making Tool.
- Approved the 2021 Annual Meeting hybrid proposal as presented and offering both an in-person meeting and a livestream option to accommodate remote participants.
- Established the in-person general registration fee of $400, and livestream general registration fee of $495 (with free On Demand access) for members for the 2021 Annual Meeting.
- Established the in-person and livestream general registration fee of $725 (with free On Demand access) for non-members for the 2021 Annual Meeting.
- Established the in-person and livestream Thursday program registration fee of $50 for members and $100 for non-members.
- Established an in-person and livestream Friday Literature Review program registration fee of $50 for members and $100 for non-members.
- Approved allocating additional funding to cover the following 2021 Annual Meeting safety-related items if they are still being mandated by the New Orleans Convention Center or local/state/federal guidelines at the time of our meeting: 1) minimal contact registration systems; 2) daily attendee temperature checks upon entry to the building; 3) crowd managers to enforce safety protocols; and 4) police detail to handle non-compliant attendees.
- Decided to encourage committees to meet virtually prior to the 2021 Annual Meeting due to the difficulty of adhering to the established social distancing requirements and to accommodate those unable to travel to the meeting.
- Decided to encourage committee chairs of relevant committees to monitor DocMatter posts and respond to questions as an individual where appropriate.
- Approved the following slate of officers and regents for election at the 2021 Annual Business Meeting:
President-Elect – Kathleen May, MD, FACAAI
Vice President – Gailen Marshall, Jr., MD, PhD, FACAAI
Treasurer – James Tracy, DO, FACAAI
Regents – Marcella Aquino, MD, FACAAI, Theresa Bingemann, MD, FACAAI, and Jeffrey Demain, MD, FACAAI
- Approved inviting Kathleen May, MD, FACAAI to deliver the Bela Schick Lecture at the 2021 Annual Meeting.
- Approved honoring Bradley Chipps, MD, FACAAI, Stephen Imbeau, MD, FACAAI, and Russell Settipane, MD, FACAAI with the Distinguished Fellow Award; Cezmi Akdis, MD with the International Distinguished Fellow Award; Rebecca Burke, JD, David Engler, MD, FACAAI, Dane McBride, MD, FACAAI, and Niraj Patel, MD, MS, FACAAI with the Distinguished Service Award; and Mervat Nassef, MD, FACAAI with the Woman in Allergy Award at the 2021 Annual Business Meeting.
- Approved the recommendation of the Gold Headed Cane Committee to include Jay Portnoy, MD, FACAAI, James Sublett, MD, FACAAI and Myron Zitt, MD, FACAAI on the 2021 Gold Headed Cane Award Ballot.
- Approved the administration of the allergy-related sleep disorders awareness membership survey developed by the Respiratory and Sleep-Related Breathing Disorders.
- Approved allocating additional funding to enable Joanna Zeiger, PhD to complete the work on the survey-related services for the International Cannabis Allergy Collaboration as outlined in her proposal with the understanding the College will have the right of first refusal to publish the survey data — from/related to all the countries — in Annals.
- Approved the proposed cover letter and survey developed by the Canna Research Foundation and authorized its distribution to ACAAI physician and Allied Health members.
- Approved expanding the SPARK program to students at Historically Black Medical Schools as presented by the Program Directors Committee and Diversity Task Force.
- Approved additional funding in 2021 for expansion of the planned NP/PA campaign to include a broader mix of allergic conditions and related content.
- Ratified the establishment of an ACAAI Technology and Telemedicine Task Force and the appointment of Tania Elliott, MD, FACAAI (chair), Sakina Bajowala, MD, Dan Dalan, MD, FACAAI, Fatima Khan, MD, FACAAI, Yudi Persaud, MD, MPH, FACAAI, Jay Portnoy, MD, FACAAI and Jennifer Shih, MD, FACAAI.
- Accepted the unaudited Financial Statements for the period ending 5/31/2021.
- Approved additional expenses to hold an in-person or hybrid Budget/Finance Committee Meeting on Oct. 2, 2021 at the O’Hare Hilton in Chicago.
- Approved the recommended revision to the Governance Manual pertaining to the selection of committee chairs and vice chairs.
- Approved the House of Delegates’ proposed 2021 Annual Town Hall Meeting Program.
- Approved the dissolution of the HOD International Region.
- Accepted the Appointments Committee’s recommendation to increase the size of the Women in Allergy Committee from 10 to 15 members.
- Continue to fund up to $164,000 in 2021 FIT travel grants at the current $500/$800 level as budgeted.
- Support the recommendation by the Joint Task Force on Practice Parameters to develop the next traditional practice parameter on immune deficiency and inform the co-chairs that the College recommends the next GRADE parameter focus on urticaria and angioedema.
- Ratified the decision to work with Pfizer on the Atopic Dermatitis proposal project and authorized the College’s president to appoint 5-7 College members to serve on an Expert Workgroup which will help to develop the program material and review the submitted grant applications.
- Approved the proposal to develop a self-assessment activity titled Using Biologics Precisely for Asthma – Patient Selection and Side Effect Management and Monitoring.
- Approved the Yardstick Task Force’s recommended topics for three new yardsticks – pruritus, penicillin allergy and chronic cough, and asked that the Task Force provide a suggested list of authors, detailed budget and a timeline for the development of each yardstick.
- Approved the Annual Meeting Site Selection Committee’s recommendation to hold the College’s 2027 Annual Meeting in Nashville contingent upon a successful site visit and contract negotiations.
- Approved the 2022 AIM project as proposed and allocated funding in the 2022 budget for development of the program.
